University Hospital Tuebingen

🇩🇪Germany
Ownership
Private
Established
1388-01-01
Employees
-
Market Cap
-
Website
https://www.klinikum.uni-heidelberg.de/Startseite.2.0.html?&no_cache=1

Intralesional Treatment With Interleukin-2 (Proleukin) in Soft Tissue Melanoma Metastases

Phase 2
Completed
Conditions
First Posted Date
2005-09-20
Last Posted Date
2011-08-19
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
51
Registration Number
NCT00204581
Locations
🇩🇪

Skin Cancer Program, Department of Dermatology, Liebermeisterstrasse 8, Tübingen, BW, Germany

Pegylated Interferon-alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB

First Posted Date
2005-09-20
Last Posted Date
2017-05-03
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
901
Registration Number
NCT00204529
Locations
🇩🇪

Arbeitsgemeinschaft Dermatologische Onkologie, Skin Cancer Program, Department of Dermatology, University of Tübingen, Tübingen, BW, Germany

Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies

Phase 1
Completed
Conditions
First Posted Date
2005-09-20
Last Posted Date
2014-05-29
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
61
Registration Number
NCT00202917
Locations
🇩🇪

Center for Marrow Transplantation, Essen, Germany

🇩🇪

University of Wuerzburg Medical Center, Wuerzburg, Germany

🇩🇪

Deutsche Klinik für Diagnostik, Wiesbaden, Germany

and more 4 locations

Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma

First Posted Date
2005-09-20
Last Posted Date
2008-10-20
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
30
Registration Number
NCT00204659
Locations
🇩🇪

University of Giessen, Giessen, Germany

🇩🇪

Schwarzwald-Baar Clinic, Villingen-Schwenningen, Germany

🇩🇪

Klinikum Reutlingen, Reutlingen, Germany

and more 2 locations

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

Phase 4
Completed
Conditions
Interventions
First Posted Date
2005-09-20
Last Posted Date
2011-08-19
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
418
Registration Number
NCT00204542
Locations
🇩🇪

Dept. of Dermatology, Freiburg, Germany

🇩🇪

Klinik fuer Dermatologie, Venerologie und Allergologie der Charite, Berlin, Germany

🇩🇪

Praxis Priv.-Doz. Dr. med. Dirschka, Wuppertal, Germany

and more 1 locations

Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)

First Posted Date
2005-09-14
Last Posted Date
2018-05-17
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
37
Registration Number
NCT00167583
Locations
🇩🇪

Department of Internal Medicine II and Department of Ophthalmology, Tuebingen, Germany

Below Study - Balloonangioplasty or Stents With ReoPro for Prevention of Subacute Reocclusion in Arteries Below the Knee

Phase 2
Conditions
First Posted Date
2005-09-13
Last Posted Date
2006-09-12
Lead Sponsor
University Hospital Tuebingen
Registration Number
NCT00163254
Locations
🇩🇪

University of Tuebingen, Tuebingen, Germany

Mirror Trial - Follow-Up Management of Peripheral Arterial Intervention With Clopidogrel

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-09-13
Last Posted Date
2011-08-09
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
80
Registration Number
NCT00163267
Locations
🇩🇪

University Hospital of Tuebingen, Tuebingen, Germany

Rio Trial - ReoPro and Peripheral Arterial Intervention to Improve Clinical Outcome in Patients With Peripheral Arterial Disease

First Posted Date
2005-09-12
Last Posted Date
2006-09-12
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
420
Registration Number
NCT00156611
Locations
🇩🇪

University of Tuebingen, Tuebingen, Germany

Thunder Trial - Local Taxan With Short Time Contact for Reduction of Restenosis in Distal Arteries

First Posted Date
2005-09-12
Last Posted Date
2006-04-25
Lead Sponsor
University Hospital Tuebingen
Target Recruit Count
135
Registration Number
NCT00156624
Locations
🇩🇪

University Hospital of Tuebingen, Tuebingen, Germany

© Copyright 2024. All Rights Reserved by MedPath